Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

Laboratory Report

Patient
Name: Nohlmans, , Maria,
DOB: 11-JUN-1947 (Age: 78)
Gender: female
Address:
Alfons-Wulff-Weg 1
25813 Husum (Germany)
ID: 6886-506417-1 (ECI)
Report
Date: 25-JUL-2022
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Dr. Wolfram Hussels Kieferorthopäde
Brinckmannstraße 35
25813 Husum (Germany)
Specimen
Collected: 25-JUL-2022

Hematology

Test 25-JUL-2022 Reference Range Unit
Leukocytes [#/volume] in Blood by Automated count 4.0 4 - 11 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 4.4 3.9 - 5.2 10*6/uL
Hemoglobin [Mass/volume] in Blood 14.1 12 - 15.5 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 44.9 38 - 54 %
MCV [Entitic volume] by Automated count 96.0 78 - 98 fL
MCH [Entitic mass] by Automated count 30.0 27 - 33 pg
MCHC [Mass/volume] by Automated count 35.1 H 31 - 35 g/dL
Erythrocyte distribution width [Ratio] by Automated count 13.5 11.5 - 16.5 %
Platelets [#/volume] in Blood by Automated count 113.7 L 150 - 450 10*3/uL

Chemistry

Test 25-JUL-2022 Reference Range Unit
Glucose [Mass/volume] in Serum or Plasma 89.9 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Serum or Plasma 19.7 7 - 20 mg/dL
Creatinine [Mass/volume] in Serum or Plasma 2.9 H 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Serum or Plasma 10.0 8.6 - 10.4 mg/dL
Sodium [Moles/volume] in Serum or Plasma 136.1 135 - 145 mmol/L
Potassium [Moles/volume] in Serum or Plasma 5.1 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Serum or Plasma 102.1 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Serum or Plasma 20.4 L 22 - 32 mmol/L
Protein [Mass/volume] in Serum or Plasma 6.5 6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.8 3.5 - 5.5 g/dL
Bilirubin.total [Mass/volume] in Serum or Plasma 12.7 H 0.3 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 56.7 44 - 142 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 0.6 L 7 - 40 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 6.3 L 10 - 40 U/L
Magnesium [Mass/volume] in Blood 2.0 1.6 - 2.3 mg/dL
Cholesterol [Mass/volume] in Serum or Plasma 279.5 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 122.4 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 192.5 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 31.0 L 50 - 120 mg/dL
Hemoglobin A1c/Hemoglobin.total in Blood 3.0 L 4.5 - 6.4 %
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Blood by Immunoassay 1.8 0 - 450 pg/mL
Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method 116.1 H 0 - 34.2 ng/L

Coagulation

Test 25-JUL-2022 Reference Range Unit
INR in Platelet poor plasma by Coagulation assay 1.1 0.9 - 1.5 {INR}
aPTT in Blood by Coagulation assay 32.3 25 - 38 s

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows significant renal impairment (elevated creatinine), marked hyperbilirubinemia, thrombocytopenia, and low liver transaminases. There is also dyslipidemia (high total and LDL cholesterol, low HDL), mild metabolic acidosis (low CO₂), and elevated cardiac troponin I, suggesting possible acute or chronic cardiac injury. Platelet count is low, which may increase bleeding risk. Further clinical correlation and urgent evaluation are recommended.